Literature DB >> 25038433

ADAM10 regulates Notch function in intestinal stem cells of mice.

Yu-Hwai Tsai1, Kelli L VanDussen2, Eric T Sawey3, Alex W Wade1, Chelsea Kasper1, Sabita Rakshit1, Riha G Bhatt1, Alex Stoeck1, Ivan Maillard4, Howard C Crawford5, Linda C Samuelson2, Peter J Dempsey6.   

Abstract

BACKGROUND & AIMS: A disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) is a cell surface sheddase that regulates physiologic processes, including Notch signaling. ADAM10 is expressed in all intestinal epithelial cell types, but the requirement for ADAM10 signaling in crypt homeostasis is not well defined.
METHODS: We analyzed intestinal tissues from mice with constitutive (Vil-Cre;Adam10(f/f) mice) and conditional (Vil-CreER;Adam10(f/f) and Leucine-rich repeat-containing GPCR5 [Lgr5]-CreER;Adam10(f/f) mice) deletion of ADAM10. We performed cell lineage-tracing experiments in mice that expressed a gain-of-function allele of Notch in the intestine (Rosa26(NICD)), or mice with intestine-specific disruption of Notch (Rosa26(DN-MAML)), to examine the effects of ADAM10 deletion on cell fate specification and intestinal stem cell maintenance.
RESULTS: Loss of ADAM10 from developing and adult intestine caused lethality associated with altered intestinal morphology, reduced progenitor cell proliferation, and increased secretory cell differentiation. ADAM10 deletion led to the replacement of intestinal cell progenitors with 2 distinct, post-mitotic, secretory cell lineages: intermediate-like (Paneth/goblet) and enteroendocrine cells. Based on analysis of Rosa26(NICD) and Rosa26(DN-MAML) mice, we determined that ADAM10 controls these cell fate decisions by regulating Notch signaling. Cell lineage-tracing experiments showed that ADAM10 is required for survival of Lgr5(+) crypt-based columnar cells. Our findings indicate that Notch-activated stem cells have a competitive advantage for occupation of the stem cell niche.
CONCLUSIONS: ADAM10 acts in a cell autonomous manner within the intestinal crypt compartment to regulate Notch signaling. This process is required for progenitor cell lineage specification and crypt-based columnar cell maintenance.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CBC; Development; Differentiation; Intestinal Epithelium

Mesh:

Substances:

Year:  2014        PMID: 25038433      PMCID: PMC4176890          DOI: 10.1053/j.gastro.2014.07.003

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  41 in total

1.  Notch signals control the fate of immature progenitor cells in the intestine.

Authors:  Silvia Fre; Mathilde Huyghe; Philippos Mourikis; Sylvie Robine; Daniel Louvard; Spyros Artavanis-Tsakonas
Journal:  Nature       Date:  2005-06-16       Impact factor: 49.962

2.  Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells.

Authors:  Johan H van Es; Marielle E van Gijn; Orbicia Riccio; Maaike van den Born; Marc Vooijs; Harry Begthel; Miranda Cozijnsen; Sylvie Robine; Doug J Winton; Freddy Radtke; Hans Clevers
Journal:  Nature       Date:  2005-06-16       Impact factor: 49.962

3.  Gfi1 functions downstream of Math1 to control intestinal secretory cell subtype allocation and differentiation.

Authors:  Noah F Shroyer; Deeann Wallis; Koen J T Venken; Hugo J Bellen; Huda Y Zoghbi
Journal:  Genes Dev       Date:  2005-10-15       Impact factor: 11.361

4.  Intestinal Neurogenin 3 directs differentiation of a bipotential secretory progenitor to endocrine cell rather than goblet cell fate.

Authors:  Lymari López-Díaz; Renu N Jain; Theresa M Keeley; Kelli L VanDussen; Cynthia S Brunkan; Deborah L Gumucio; Linda C Samuelson
Journal:  Dev Biol       Date:  2007-07-24       Impact factor: 3.582

Review 5.  The intestinal crypt, a prototype stem cell compartment.

Authors:  Hans Clevers
Journal:  Cell       Date:  2013-07-18       Impact factor: 41.582

6.  Clonal analysis of mouse intestinal epithelial progenitors.

Authors:  M Bjerknes; H Cheng
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

7.  Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE.

Authors:  Marc Vooijs; Chin-Tong Ong; Brandon Hadland; Stacey Huppert; Zhenyi Liu; Jeroen Korving; Maaike van den Born; Thaddeus Stappenbeck; Yumei Wu; Hans Clevers; Raphael Kopan
Journal:  Development       Date:  2007-02       Impact factor: 6.868

8.  Pancreatic islet progenitor cells in neurogenin 3-yellow fluorescent protein knock-add-on mice.

Authors:  Georg Mellitzer; Mercè Martín; Marjorie Sidhoum-Jenny; Christophe Orvain; Jochen Barths; Philip A Seymour; Maike Sander; Gérard Gradwohl
Journal:  Mol Endocrinol       Date:  2004-08-05

9.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

10.  Notch signaling is an important regulator of type 2 immunity.

Authors:  Lili Tu; Terry C Fang; David Artis; Olga Shestova; Seth E Pross; Ivan Maillard; Warren S Pear
Journal:  J Exp Med       Date:  2005-10-17       Impact factor: 14.307

View more
  42 in total

Review 1.  Factors regulating quiescent stem cells: insights from the intestine and other self-renewing tissues.

Authors:  Camilla A Richmond; Manasvi S Shah; Diana L Carlone; David T Breault
Journal:  J Physiol       Date:  2016-01-18       Impact factor: 5.182

Review 2.  ADAM Proteases and Gastrointestinal Function.

Authors:  Jennifer C Jones; Shelly Rustagi; Peter J Dempsey
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

Review 3.  Notch regulation of gastrointestinal stem cells.

Authors:  Elise S Demitrack; Linda C Samuelson
Journal:  J Physiol       Date:  2016-06-26       Impact factor: 5.182

Review 4.  Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis.

Authors:  Peter J Dempsey
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-07-22       Impact factor: 4.739

5.  PRC2 preserves intestinal progenitors and restricts secretory lineage commitment.

Authors:  Fulvio Chiacchiera; Alessandra Rossi; SriGanesh Jammula; Marika Zanotti; Diego Pasini
Journal:  EMBO J       Date:  2016-09-01       Impact factor: 11.598

6.  ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet-associated Colon Cancer.

Authors:  Reba Mustafi; Urszula Dougherty; Devkumar Mustafi; Fatma Ayaloglu-Butun; Michelle Fletcher; Sarbani Adhikari; Farhana Sadiq; Katherine Meckel; Haider I Haider; Abdurahman Khalil; Joel Pekow; Vani Konda; Loren Joseph; John Hart; Alessandro Fichera; Yan Chun Li; Marc Bissonnette
Journal:  Clin Cancer Res       Date:  2016-08-03       Impact factor: 12.531

Review 7.  Recapitulating Human Gastric Cancer Pathogenesis: Experimental Models of Gastric Cancer.

Authors:  Lin Ding; Mohamad El Zaatari; Juanita L Merchant
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

8.  Loss of ADAM17-Mediated Tumor Necrosis Factor Alpha Signaling in Intestinal Cells Attenuates Mucosal Atrophy in a Mouse Model of Parenteral Nutrition.

Authors:  Yongjia Feng; Yu-Hwai Tsai; Weidong Xiao; Matthew W Ralls; Alex Stoeck; Carole L Wilson; Elaine W Raines; Daniel H Teitelbaum; Peter J Dempsey
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

9.  Unsupervised Trajectory Analysis of Single-Cell RNA-Seq and Imaging Data Reveals Alternative Tuft Cell Origins in the Gut.

Authors:  Charles A Herring; Amrita Banerjee; Eliot T McKinley; Alan J Simmons; Jie Ping; Joseph T Roland; Jeffrey L Franklin; Qi Liu; Michael J Gerdes; Robert J Coffey; Ken S Lau
Journal:  Cell Syst       Date:  2017-11-15       Impact factor: 10.304

Review 10.  Stem cell and progenitor fate in the mammalian intestine: Notch and lateral inhibition in homeostasis and disease.

Authors:  Rocio Sancho; Catherine A Cremona; Axel Behrens
Journal:  EMBO Rep       Date:  2015-04-08       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.